Immuno-Oncology Market Report

China Immuno-Oncology Industry Market Research Report 2023-2029

  • POSTDATE：Aug 22, 2023
  • PAGES：177
  • REPORT CODE：GMM1750110
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Immuno-Oncology industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • AstraZeneca, Plc

    • Bavarian Nordic

    • EMD Serono

    • Galena Biopharma

    • Novartis International AG

    • Johnson & Johnson

    • AbbVie

    • Amgen Inc

    • Celldex Therapeutics

    • Incyte

    • Aduro BioTech

    • Celgene Corporation

    • Sanofi SA

    • Bristol-Myers Squibb

    • Hoffmann-La Roche AG

    • Merck & Co

    • Eli Lilly and Company

    • Prometheus Therapeutics & Diagnostics

    By Type:

    • Cancer Vaccines

    • Immune Checkpoint Inhibitors

    • CAR-T Cell Therapy

    • Cytokine-Based Immunotherapy

    • Monoclonal Antibodies

    By Application:

    • Hospitals

    • Pharmacies

    • Online Pharmacies

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Immuno-Oncology Market Overview 2018-2029

    • 1.1 China Immuno-Oncology Industry Development Overview

    • 1.2 China Immuno-Oncology Industry Development History

    • 1.3 China Immuno-Oncology Industry Market Size (2018-2029)

    • 1.4 China Immuno-Oncology Market Analysis by Type from Production Side

      • 1.4.1 China Immuno-Oncology Production Volume, Production Value and Growth Rate of Cancer Vaccines (2018-2029)

      • 1.4.2 China Immuno-Oncology Production Volume, Production Value and Growth Rate of Immune Checkpoint Inhibitors (2018-2029)

      • 1.4.3 China Immuno-Oncology Production Volume, Production Value and Growth Rate of CAR-T Cell Therapy (2018-2029)

      • 1.4.4 China Immuno-Oncology Production Volume, Production Value and Growth Rate of Cytokine-Based Immunotherapy (2018-2029)

      • 1.4.5 China Immuno-Oncology Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)

    • 1.5 China Immuno-Oncology Market Analysis by Application from Consumption End

      • 1.5.1 China Immuno-Oncology Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

      • 1.5.2 China Immuno-Oncology Sales Volume, Sales Value and Growth Rate of Pharmacies (2018-2029)

      • 1.5.3 China Immuno-Oncology Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)

    • 1.6 China Immuno-Oncology Market Analysis by Region

      • 1.6.1 North China Immuno-Oncology Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Immuno-Oncology Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Immuno-Oncology Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Immuno-Oncology Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Immuno-Oncology Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Immuno-Oncology Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Immuno-Oncology Market Size and Growth Rate from 2018-2029

    Chapter 2 China Immuno-Oncology Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Immuno-Oncology Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Immuno-Oncology Market Status and Competition Analysis in 2023

      • 2.2.3 China Immuno-Oncology Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Immuno-Oncology Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Immuno-Oncology Industry Development

    Chapter 3 Immuno-OncologyIndustry Chain Analysis

    • 3.1 Immuno-Oncology Industry Chain

    • 3.2 Immuno-Oncology Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Immuno-Oncology Market

    • 3.3 Immuno-Oncology Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Immuno-Oncology Market

    Chapter 4 China Immuno-Oncology Market, by Type

    • 4.1 China Immuno-Oncology Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Immuno-Oncology Total Production Volume and Growth Rate from Production Side

    • 4.5 China Immuno-Oncology Production Volume and Growth Rate, by Type

      • 4.5.1 China Immuno-Oncology Production Volume and Growth Rate of Cancer Vaccines

      • 4.5.2 China Immuno-Oncology Production Volume and Growth Rate of Immune Checkpoint Inhibitors

      • 4.5.3 China Immuno-Oncology Production Volume and Growth Rate of CAR-T Cell Therapy

      • 4.5.4 China Immuno-Oncology Production Volume and Growth Rate of Cytokine-Based Immunotherapy

      • 4.5.5 China Immuno-Oncology Production Volume and Growth Rate of Monoclonal Antibodies

    Chapter 5 China Immuno-Oncology Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Immuno-Oncology Total Market Size and Growth Rate from Consumption End

    • 5.5 China Immuno-Oncology Market Size and Growth Rate, by Application

      • 5.5.1 China Immuno-Oncology Market Size and Growth Rate of Hospitals

      • 5.5.2 China Immuno-Oncology Market Size and Growth Rate of Pharmacies

      • 5.5.3 China Immuno-Oncology Market Size and Growth Rate of Online Pharmacies

    Chapter 6 China Immuno-Oncology Market, by Region

    • 6.1 China Immuno-Oncology Production Volume and Production Value, by Region

    • 6.2 China Immuno-Oncology Sales Volume and Sales Value, by Region

    Chapter 7 North China Immuno-Oncology Market Analysis

    • 7.1 North China Immuno-Oncology Market, by Type

    • 7.2 North China Immuno-Oncology Market, by Application

    Chapter 8 Central China Immuno-Oncology Market Analysis

    • 8.1 Central China Immuno-Oncology Market, by Type

    • 8.2 Central China Immuno-Oncology Market, by Application

    Chapter 9 South China Immuno-Oncology Market Analysis

    • 9.1 South China Immuno-Oncology Market, by Type

    • 9.2 South China Immuno-Oncology Market, by Application

    Chapter 10 East China Immuno-Oncology Market Analysis

    • 10.1 East China Immuno-Oncology Market, by Type

    • 10.2 East China Immuno-Oncology Market, by Application

    Chapter 11 Northeast China Immuno-Oncology Market Analysis

    • 11.1 Northeast China Immuno-Oncology Market, by Type

    • 11.2 Northeast China Immuno-Oncology Market, by Application

    Chapter 12 Southwest China Immuno-Oncology Market Analysis

    • 12.1 Southwest China Immuno-Oncology Market, by Type

    • 12.2 Southwest China Immuno-Oncology Market, by Application

    Chapter 13 Northwest China Immuno-Oncology Market Analysis

    • 13.1 Northwest China Immuno-Oncology Market, by Type

    • 13.2 Northwest China Immuno-Oncology Market, by Application

    Chapter 14 Company Profiles

      • 14.1 AstraZeneca, Plc

        • 14.1.1 AstraZeneca, Plc Company Profile

        • 14.1.2 AstraZeneca, Plc Immuno-Oncology Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Bavarian Nordic

        • 14.2.1 Bavarian Nordic Company Profile

        • 14.2.2 Bavarian Nordic Immuno-Oncology Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 EMD Serono

        • 14.3.1 EMD Serono Company Profile

        • 14.3.2 EMD Serono Immuno-Oncology Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Galena Biopharma

        • 14.4.1 Galena Biopharma Company Profile

        • 14.4.2 Galena Biopharma Immuno-Oncology Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Novartis International AG

        • 14.5.1 Novartis International AG Company Profile

        • 14.5.2 Novartis International AG Immuno-Oncology Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Johnson & Johnson

        • 14.6.1 Johnson & Johnson Company Profile

        • 14.6.2 Johnson & Johnson Immuno-Oncology Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 AbbVie

        • 14.7.1 AbbVie Company Profile

        • 14.7.2 AbbVie Immuno-Oncology Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Amgen Inc

        • 14.8.1 Amgen Inc Company Profile

        • 14.8.2 Amgen Inc Immuno-Oncology Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Celldex Therapeutics

        • 14.9.1 Celldex Therapeutics Company Profile

        • 14.9.2 Celldex Therapeutics Immuno-Oncology Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Incyte

        • 14.10.1 Incyte Company Profile

        • 14.10.2 Incyte Immuno-Oncology Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Aduro BioTech

        • 14.11.1 Aduro BioTech Company Profile

        • 14.11.2 Aduro BioTech Immuno-Oncology Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Celgene Corporation

        • 14.12.1 Celgene Corporation Company Profile

        • 14.12.2 Celgene Corporation Immuno-Oncology Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Sanofi SA

        • 14.13.1 Sanofi SA Company Profile

        • 14.13.2 Sanofi SA Immuno-Oncology Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Bristol-Myers Squibb

        • 14.14.1 Bristol-Myers Squibb Company Profile

        • 14.14.2 Bristol-Myers Squibb Immuno-Oncology Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Hoffmann-La Roche AG

        • 14.15.1 Hoffmann-La Roche AG Company Profile

        • 14.15.2 Hoffmann-La Roche AG Immuno-Oncology Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Merck & Co

        • 14.16.1 Merck & Co Company Profile

        • 14.16.2 Merck & Co Immuno-Oncology Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Eli Lilly and Company

        • 14.17.1 Eli Lilly and Company Company Profile

        • 14.17.2 Eli Lilly and Company Immuno-Oncology Market Performance

        • 14.17.3 Product&Service Introduction

      • 14.18 Prometheus Therapeutics & Diagnostics

        • 14.18.1 Prometheus Therapeutics & Diagnostics Company Profile

        • 14.18.2 Prometheus Therapeutics & Diagnostics Immuno-Oncology Market Performance

        • 14.18.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Immuno-Oncology Industry Research Conclusions

    • 15.2 Immuno-Oncology Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Immuno-Oncology Industry Market Size (2018-2029)

    • Figure China Immuno-Oncology Production Volume, Production Value and Growth Rate of Cancer Vaccines (2018-2029)

    • Figure China Immuno-Oncology Production Volume, Production Value and Growth Rate of Immune Checkpoint Inhibitors (2018-2029)

    • Figure China Immuno-Oncology Production Volume, Production Value and Growth Rate of CAR-T Cell Therapy (2018-2029)

    • Figure China Immuno-Oncology Production Volume, Production Value and Growth Rate of Cytokine-Based Immunotherapy (2018-2029)

    • Figure China Immuno-Oncology Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)

    • Figure China Immuno-Oncology Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure China Immuno-Oncology Sales Volume, Sales Value and Growth Rate of Pharmacies (2018-2029)

    • Figure China Immuno-Oncology Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)

    • Figure North China Immuno-Oncology Market Size and Growth Rate from 2018-2029

    • Figure Central China Immuno-Oncology Market Size and Growth Rate from 2018-2029

    • Figure South China Immuno-Oncology Market Size and Growth Rate from 2018-2029

    • Figure East China Immuno-Oncology Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Immuno-Oncology Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Immuno-Oncology Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Immuno-Oncology Market Size and Growth Rate from 2018-2029

    • Figure Immuno-Oncology Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Immuno-Oncology Market Share by Type in 2018

    • Figure China Immuno-Oncology Market Share by Type in 2023

    • Figure China Immuno-Oncology Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Immuno-Oncology Production Volume and Growth Rate of Cancer Vaccines (2018-2023)

    • Figure China Immuno-Oncology Production Volume and Growth Rate of Immune Checkpoint Inhibitors (2018-2023)

    • Figure China Immuno-Oncology Production Volume and Growth Rate of CAR-T Cell Therapy (2018-2023)

    • Figure China Immuno-Oncology Production Volume and Growth Rate of Cytokine-Based Immunotherapy (2018-2023)

    • Figure China Immuno-Oncology Production Volume and Growth Rate of Monoclonal Antibodies (2018-2023)

    • Figure China Immuno-Oncology Market Share by Application in 2018

    • Figure China Immuno-Oncology Market Share by Application in 2023

    • Figure China Immuno-Oncology Total Market Size and Growth Rate from Consumption End

    • Figure China Immuno-Oncology Market Size and Growth Rate of Hospitals (2018-2023)

    • Figure China Immuno-Oncology Market Size and Growth Rate of Pharmacies (2018-2023)

    • Figure China Immuno-Oncology Market Size and Growth Rate of Online Pharmacies (2018-2023)

    • Table China Immuno-Oncology Production Volume by Region (2018-2023)

    • Table China Immuno-Oncology Production Volume Share by Region (2018-2023)

    • Figure China Immuno-Oncology Production Volume Share by Region (2018-2023)

    • Table China Immuno-Oncology Production Value by Region (2018-2023)

    • Table China Immuno-Oncology Production Value Share by Region (2018-2023)

    • Figure China Immuno-Oncology Production Value Share by Region (2018-2023)

    • Table China Immuno-Oncology Sales Volume by Region (2018-2023)

    • Table China Immuno-Oncology Sales Volume Share by Region (2018-2023)

    • Figure China Immuno-Oncology Sales Volume Share by Region (2018-2023)

    • Table China Immuno-Oncology Sales Value by Region (2018-2023)

    • Table China Immuno-Oncology Sales Value Share by Region (2018-2023)

    • Figure China Immuno-Oncology Sales Value Share by Region (2018-2023)

    • Table North China Immuno-Oncology Production Volume by Type (2018-2023)

    • Table North China Immuno-Oncology Production Volume Share by Type (2018-2023)

    • Figure North China Immuno-Oncology Production Volume Share by Type (2018-2023)

    • Table North China Immuno-Oncology Sales Volume by Application (2018-2023)

    • Table North China Immuno-Oncology Sales Volume Share by Application (2018-2023)

    • Figure North China Immuno-Oncology Sales Volume Share by Application (2018-2023)

    • Table Central China Immuno-Oncology Production Volume by Type (2018-2023)

    • Table Central China Immuno-Oncology Production Volume Share by Type (2018-2023)

    • Figure Central China Immuno-Oncology Production Volume Share by Type (2018-2023)

    • Table Central China Immuno-Oncology Sales Volume by Application (2018-2023)

    • Table Central China Immuno-Oncology Sales Volume Share by Application (2018-2023)

    • Figure Central China Immuno-Oncology Sales Volume Share by Application (2018-2023)

    • Table South China Immuno-Oncology Production Volume by Type (2018-2023)

    • Table South China Immuno-Oncology Production Volume Share by Type (2018-2023)

    • Figure South China Immuno-Oncology Production Volume Share by Type (2018-2023)

    • Table South China Immuno-Oncology Sales Volume by Application (2018-2023)

    • Table South China Immuno-Oncology Sales Volume Share by Application (2018-2023)

    • Figure South China Immuno-Oncology Sales Volume Share by Application (2018-2023)

    • Table East China Immuno-Oncology Production Volume by Type (2018-2023)

    • Table East China Immuno-Oncology Production Volume Share by Type (2018-2023)

    • Figure East China Immuno-Oncology Production Volume Share by Type (2018-2023)

    • Table East China Immuno-Oncology Sales Volume by Application (2018-2023)

    • Table East China Immuno-Oncology Sales Volume Share by Application (2018-2023)

    • Figure East China Immuno-Oncology Sales Volume Share by Application (2018-2023)

    • Table Northeast China Immuno-Oncology Production Volume by Type (2018-2023)

    • Table Northeast China Immuno-Oncology Production Volume Share by Type (2018-2023)

    • Figure Northeast China Immuno-Oncology Production Volume Share by Type (2018-2023)

    • Table Northeast China Immuno-Oncology Sales Volume by Application (2018-2023)

    • Table Northeast China Immuno-Oncology Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Immuno-Oncology Sales Volume Share by Application (2018-2023)

    • Table Southwest China Immuno-Oncology Production Volume by Type (2018-2023)

    • Table Southwest China Immuno-Oncology Production Volume Share by Type (2018-2023)

    • Figure Southwest China Immuno-Oncology Production Volume Share by Type (2018-2023)

    • Table Southwest China Immuno-Oncology Sales Volume by Application (2018-2023)

    • Table Southwest China Immuno-Oncology Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Immuno-Oncology Sales Volume Share by Application (2018-2023)

    • Table Northwest China Immuno-Oncology Production Volume by Type (2018-2023)

    • Table Northwest China Immuno-Oncology Production Volume Share by Type (2018-2023)

    • Figure Northwest China Immuno-Oncology Production Volume Share by Type (2018-2023)

    • Table Northwest China Immuno-Oncology Sales Volume by Application (2018-2023)

    • Table Northwest China Immuno-Oncology Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Immuno-Oncology Sales Volume Share by Application (2018-2023)

    • Table AstraZeneca, Plc Company Profile

    • Table AstraZeneca, Plc Immuno-Oncology Revenue, Price and Gross (2018-2023)

    • Table Bavarian Nordic Company Profile

    • Table Bavarian Nordic Immuno-Oncology Revenue, Price and Gross (2018-2023)

    • Table EMD Serono Company Profile

    • Table EMD Serono Immuno-Oncology Revenue, Price and Gross (2018-2023)

    • Table Galena Biopharma Company Profile

    • Table Galena Biopharma Immuno-Oncology Revenue, Price and Gross (2018-2023)

    • Table Novartis International AG Company Profile

    • Table Novartis International AG Immuno-Oncology Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Immuno-Oncology Revenue, Price and Gross (2018-2023)

    • Table AbbVie Company Profile

    • Table AbbVie Immuno-Oncology Revenue, Price and Gross (2018-2023)

    • Table Amgen Inc Company Profile

    • Table Amgen Inc Immuno-Oncology Revenue, Price and Gross (2018-2023)

    • Table Celldex Therapeutics Company Profile

    • Table Celldex Therapeutics Immuno-Oncology Revenue, Price and Gross (2018-2023)

    • Table Incyte Company Profile

    • Table Incyte Immuno-Oncology Revenue, Price and Gross (2018-2023)

    • Table Aduro BioTech Company Profile

    • Table Aduro BioTech Immuno-Oncology Revenue, Price and Gross (2018-2023)

    • Table Celgene Corporation Company Profile

    • Table Celgene Corporation Immuno-Oncology Revenue, Price and Gross (2018-2023)

    • Table Sanofi SA Company Profile

    • Table Sanofi SA Immuno-Oncology Revenue, Price and Gross (2018-2023)

    • Table Bristol-Myers Squibb Company Profile

    • Table Bristol-Myers Squibb Immuno-Oncology Revenue, Price and Gross (2018-2023)

    • Table Hoffmann-La Roche AG Company Profile

    • Table Hoffmann-La Roche AG Immuno-Oncology Revenue, Price and Gross (2018-2023)

    • Table Merck & Co Company Profile

    • Table Merck & Co Immuno-Oncology Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly and Company Company Profile

    • Table Eli Lilly and Company Immuno-Oncology Revenue, Price and Gross (2018-2023)

    • Table Prometheus Therapeutics & Diagnostics Company Profile

    • Table Prometheus Therapeutics & Diagnostics Immuno-Oncology Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US